Pharmaceutical Suspension Manufacturer in India

WHO-GMP certified oral suspension manufacturing — analgesic, antibiotic, antifungal, antacid and paediatric formulations — reconstitutable dry suspensions and ready-to-use variants for domestic supply and international export.

Key Highlights

WHO-GMP
Certified Facility
Dry · Ready-to-use
· Paediatric
15+ Countries
Supplied
DCGI Approved
Formulations

Request A Product List

Download Capability Brochure

About Suspensions

Suspension manufacturing
expertise at 9M India

9M India manufactures a comprehensive range of pharmaceutical oral suspensions from a WHO-GMP certified facility in Birkoni, Chhattisgarh. Our suspension portfolio covers reconstitutable dry suspensions and ready-to-use liquid suspensions across analgesic,
antibiotic, antifungal, antiprotozoal, antacid, antiparasitic, gastrointestinal, respiratory and nutritional therapeutic categories.

Suspension manufacturing presents unique formulation challenges — uniform particle size distribution, adequate viscosity for dose uniformity, physical stability against settling and acceptable taste for patient compliance. At 9M India, each suspension formulation is developed with these critical quality attributes as primary design criteria, with physical stability and dose uniformity validated at manufacture and across shelf life.

Antibiotic dry suspensions — including Amoxicillin, Cefixime and Metronidazole — are manufactured in humidity-controlled environments to prevent premature moisture uptake. Antacid suspensions containing Aluminium hydroxide and Magnesium hydroxide are formulated for appropriate neutralising capacity and physical stability against creaming and caking. Paediatric suspensions use taste-masked particle systems with age-appropriate flavouring validated for palatability.

Reconstitutable dry suspensions and ready-to-use liquid suspensions
Antibiotic, antifungal, antacid, analgesic and paediatric formulations
Humidity-controlled manufacturing for dry suspension products
Validated dose uniformity and physical stability across shelf life
DCGI-approved — glass and PET bottle packaging with child-resistant closures

Enquire Now

Our Capabilities

Suspension manufacturing
capabilities at 9M India

01

Reconstitutable dry suspensions are manufactured as free-flowing powder blends that produce uniform suspension upon addition of specified volume of water at point of use. Manufacturing is conducted in humidity-controlled environments to prevent premature moisture uptake and caking. Critical quality attributes monitored during production include blend uniformity, particle size distribution, moisture content and reconstitution ease. Post- reconstitution stability testing is conducted at recommended storage conditions.
02

Liquid suspension manufacturing using closed stainless steel vessel systems with controlled mixing speed, temperature and homogenisation to achieve uniform particle size and consistent suspension viscosity. Suspending agents — including xanthan gum, sodium carboxymethylcellulose and microcrystalline cellulose — are selected based on rheology requirements and compatibility with the active pharmaceutical ingredient. Sedimentation rates are monitored during stability studies.
03

Paediatric oral suspensions require careful attention to taste masking, age-appropriate dosing, physical stability and ease of administration. 9M India develops paediatric suspension formulations with microencapsulated or resin-complexed active ingredients for taste masking, appropriate dose volumes for weight-based dosing, and dosing devices calibrated for accurate administration. Palatability validation is conducted as part of formulation development.
04

Antacid suspensions containing Aluminium hydroxide, Magnesium hydroxide and combination antacid formulations require specific manufacturing controls to achieve consistent neutralising capacity and physical stability. Manufacturing parameters include controlled particle size of antacid actives, viscosity specification, settling rate and neutralising capacity per dose. Combination antacid suspensions with simethicone addition are manufactured with validated defoaming performance.
05

Suspension packaging in amber glass and PET bottles with tamper-evident and child- resistant closures. Reconstitution marks and dosing instructions included on primary label. Multi-lingual labelling for export markets. Complete documentation — Manufacturing Licence, DCGI approvals, WHO-GMP Certificate, COA, COC, stability data and product dossiers — pre- prepared for tender and export submission.

Therapeutic Categories

Suspension formulations across major therapeutic categories

Analgesic & Antipyretic
- Paracetamol suspension
- Ibuprofen suspension
Anti-infective
- Antibiotic
- Antifungal
- Antiprotozoal
- Amoxicillin suspension
- Cefixime suspension
- Metronidazole
- Nystatin
Gastrointestinal
- Antacids
- Anti-ulcer
- Laxative
- Aluminium + Magnesium hydroxide
- Sucralfate
- Lactulose
Respiratory
- Antihistamine
- Bronchodilator
- Chlorpheniramine
- Salbutamol suspension
CNS & Antiparasitic
- Carbamazepine suspension
- Albendazole suspension
- Cetirizine suspension

Why Choose Us

Why choose 9M India for
suspension manufacturing

Dry and ready-to-use. Both manufactured. Same WHO-GMP standard.

Reconstitutable dry suspensions for antibiotic and paediatric formulations and ready-to-use liquid suspensions for antacids and analgesics — both manufactured at 9M India under identical compliance standards.
Humidity-controlled dry suspension manufacturing.

Antibiotic dry suspensions are moisture-sensitive. Our facility maintains the humidity-controlled manufacturing and packaging environments required to prevent caking and ensure consistent reconstitution every batch.
Dose uniformity. Validated across shelf life.

Physical stability — sedimentation, caking and resuspendability — is monitored throughout shelf life for every suspension formulation. Dose uniformity at top, middle and bottom of container is validated before commercial release.

Our Suspensions Range

Key suspension formulations manufactured at 9M India

01

Paracetamol Suspension | Analgesic | Ready-to-use | Non-opioid
02

Ibuprofen Suspension | Anti-inflammatory | Ready-to-use | NSAID
03

Amoxicillin Suspension | Antibiotic | Reconstitutable | Penicillin
04

Cefixime Suspension | Antibiotic | Reconstitutable | Cephalosporin
05

Metronidazole Suspension | Antiprotozoal | Ready-to-use | Nitroimidazole
06

Nystatin Suspension | Antifungal | Ready-to-use | Polyene antifungal
07

Aluminium+Magnesium Hydroxide | Antacid | Ready-to-use | Antacid combination
08

Albendazole Suspension | Antiparasitic | Ready-to-use | Benzimidazole
09

Carbamazepine Suspension | CNS | Ready-to-use | Antiepileptic
10

Cetirizine Suspension | Allergy | Ready-to-use | Antihistamine
11

Salbutamol Suspension | Respiratory | Ready-to-use | Bronchodilator
12

Lactulose Suspension | Gastrointestinal | Ready-to-use | Osmotic laxative

We keep answer short

Frequently asked questions —
suspension manufacturing

01

Both reconstitutable dry suspensions and ready-to-use liquid suspensions — covering antibiotic, antifungal, antacid, analgesic, antiparasitic, CNS and paediatric therapeutic categories.
02

Yes — Amoxicillin, Cefixime, Co-amoxiclav and Metronidazole dry suspensions. Manufactured in humidity-controlled environments with validated reconstitution and post-reconstitution stability.
03

Dose uniformity is validated at top, middle and bottom of container at manufacture and throughout stability studies. Physical stability — sedimentation rate, resuspendability and viscosity — is monitored across shelf life.
04

Yes — with taste-masked, weight-based dosing and child-resistant closure options. Palatability validation is conducted as part of paediatric formulation development.
05

COA, COC, stability data, physical stability records, DCGI approvals, WHO-GMP certificate and product dossiers — all pre-prepared and available within 24 hours.